Would-be partners wage angry feud

The angry exchanges between Emergent BioSolutions and Protein Sciences keep getting nastier.  Both companies now accuse each other of breaking their $78 million merger pact, and the accusations are likely to continue to ring in an ongoing lawsuit. This week Emergent revised its offer for Protein Sciences, but Protein Sciences says the deal is off. Report

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Since the Warp Speed selections went public, experts have been wondering why some drugmakers were left off.

A few years ago, one of our Fierce editors met a Big Pharma R&D chief for the first time. “You’re the ones with the scary name,” he joked.